Basel, Switzerland
Based on a novel technology platform, we develop age-appropriate formulations that feature faster oral disintegration, better taste masking and higher drug loading compared to currently available oral dosage forms. Proven through our own generic product portfolio and providing major benefits in time, risk and costs for new API drug development, our technology leads to better patient compliance and convenience.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Galvita on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
